Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With new name, new CEO, Cascadian now rolls out a new pivotal plan for lead cancer drug
With new name, new CEO, Cascadian now rolls out a new pivotal plan for lead cancer drug
With new name, new CEO, Cascadian now rolls out a new pivotal plan for lead cancer drug
Submitted by
admin
on December 7, 2016 - 10:16am
Source:
Endpoints
News Tags:
Oncothyreon
Cascadian
tucatinib
ONT-380
treatment-resistant breast cancer
breast cancer
Headline:
With new name, new CEO, Cascadian now rolls out a new pivotal plan for lead cancer drug
Do Not Allow Advertisers to Use My Personal information
